Reaction
Human Herpesvirus 6 Infection Reactivation reporting signals
As of the last recalculation, Human Herpesvirus 6 Infection Reactivation appears in 343 FAERS reports alongside 18 co-occurring drug terms. The strongest observed disproportionality signal is THIOTEPA (PRR 201.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Thiotepa | 29 | 201.2 | 201.8 |
| Fludarabine Phosphate | 69 | 133.0 | 133.3 |
| Busulfan | 29 | 122.1 | 122.3 |
| Melphalan | 37 | 110.5 | 110.7 |
| Alemtuzumab | 29 | 99.3 | 99.4 |
| Melphalan Hydrochloride | 36 | 97.2 | 97.4 |
| Basiliximab | 14 | 75.3 | 75.4 |
| Amphotericin B | 12 | 60.2 | 60.2 |
| Zonisamide | 14 | 59.8 | 59.9 |
| Norepinephrine | 10 | 58.4 | 58.5 |
| Itraconazole | 10 | 53.5 | 53.5 |
| Sirolimus | 11 | 51.2 | 51.2 |
| Valganciclovir Hydrochloride Powder, | 9 | 46.0 | 46.0 |
| Mycophenilic Acid | 15 | 45.9 | 45.9 |
| Norepinephrine Bitartrate | 10 | 43.4 | 43.4 |
| Gentamicin | 9 | 42.9 | 42.9 |
| Azacitidine For | 6 | 20.4 | 20.4 |
| Axicabtagene Ciloleucel | 3 | 18.6 | 18.6 |